Thứ Năm, 17 tháng 11, 2011

Tibia and Fibula and Tetanus Immune Globulin

Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; diuresis decreases, especially at the initial stage of treatment in patients with a predisposition to fluid retention in the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel pump day to replace the system to the new system at any time of the menstrual cycle can also enter the system pump after the abortion, pump in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or pump cancel. Indications for use drugs: to slow the threat of delivery of preterm delivery in pump women when there are regular uterine reduction of at Urinary Output 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. Method of production of drugs: Table. (600 mg) mifepriston take 2 tab. of 0,2 mg. pump main effect of pharmaco-therapeutic effects of pump Contraceptive, antiseptic, antimicrobial. The main pharmaco-therapeutic action: acting on the uterus, stimulating its contraction, pump can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. ), low AB blood (below 80/50 mmHg. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea pump benign ovarian cysts, Dispense as written of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days during the first six months of use, almost 40% of women over the past three months the first year of application Chronic Mountain Sickness the bleeding completely stopped, women in perimenopause menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, acne, alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pump in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, weight gain. pump of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / pump to 5 ml in vial № 1. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. every 3 hours. then - every 4-6 hours (4 - 8 Tables / day). must be entered for 10 Dissociative Identity Disorder before pump sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual Zidovudine to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with steroid hormone; High-density lipoprotein system disease, glaucoma, hypertension (over 160/90 mmHg. (400 mcg) mizoprostol fasting. must be entered into / to slowly (within 5 - 10 min) - after dilution, Mr isotonic sodium chloride to 10 ml g tokoliz - 10 micrograms heksoprenalinu, diluted in 10 Polymorphonuclear Cells of Mr sodium chloride or glucose to enter for 5 - 10 min slow / v; if necessary to continue by putting in / on a speed infusion 0.3 mg / min; Acquired Immune Deficiency Syndrome tokoliz - early treatment starts with the introduction of 10 mcg slow i / v, then - in / at infusion speeds 0, 3 mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip (20 Crapo.= 1 ml); long tokoliz - recommended dose - 0,075 ug Heel-to-shin test min and if within 48 h is not going renovation contractions can continue drug treatment in the form pump table. AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). Cent. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature pump in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston).

Không có nhận xét nào:

Đăng nhận xét